Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimethoprim-sulfamethoxazole versus benzathine penicillin for impetigo in Aboriginal children
ACTRN12609000858291Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of trimethoprim + sulfamethoxazole and benzathine penicillin G in impetigo (3 arms), sponsored by Menzies School of Health Research. Primary endpoint: Clinical treatment success at day 7. Started Nov 2009; status: completed.
02
Drugs
trimethoprim + sulfamethoxazolebenzathine penicillin G
03
Conditions
impetigo
Beyond the preview
Go deeper on ACTRN12609000858291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000858291.